Clinical Trial Update: IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM) [NA]

View source ↗

Summary

Clinical trial completion for IntelliCare AIM, an AI-driven mobile intervention for depression and anxiety, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• IntelliCare AIM

Snippet

Sponsor: Northwestern University | Conditions: Major Depressive Disorder, Anxiety Disorders | NA | Status: COMPLETED | Results posted: 2018-10-29